HIV transmission prevention Other
Conditions
Interventions
Participants will complete the 'ePrEP Clinic' pathway instead of their usual in-clinic interim PrEP review. The ePrEP Clinic consists of postal self-sampling for HIV and STIs, an asynchronous online c
Sponsors
Glasgow Caledonian University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Reside in the Greater Glasgow and Clyde health board 2. Existing Sandyford PrEP service user 3. Currently use tenofovir disoproxil and emtricitabine for PrEP (‘standard’ oral PrEP) 4. Willing and able to receive the postal self-sampling kit 5. Does not require enhanced kidney (renal) monitoring at that visit 5.1. Is aged 18-39 years 5.2. No known medical conditions that increase kidney risks 5.3. No known medications that interact with kidney function or are associated with kidney impairment 5.4. Does not have >1 + protein on previous urinalysis 6. No scheduled testing that cannot be delivered within the ePrEP Clinic (e.g. urinalysis, hepatitis B/C testing) 7. Not prescribed interacting medications 8. Not known to have viral hepatitis 9. Not known to have osteoporosis or be at significant risk of osteoporosis 10. Not pregnant or a cis woman not on contraception 11. No known ‘social complexities’ as determined by a clinician using local criteria 12. No significant PrEP adherence issues 13. Able to read English well enough to understand the study materials (including self-sampling instructions and asynchronous consultation), and provide informed consent
Exclusion criteria
Exclusion criteria: Anyone who does not fulfil all inclusion criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uptake and completion rate measured by tracking participants' completion of each of the pathway stages over the course of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Clinical input required by participants measured by logging clinical input received throughout participation 2. Acceptability measured using a self-report questionnaire at the end of the study 3. Costs associated with the ePrEP Clinic pathway measured by conducting a costing analysis using study data (primarily, mapping participants' journeys through the intervention and the resources used) 4. Details of any challenges or lessons learned when implementing the study measured by maintaining a log throughout the study period | — |
Countries
Scotland, United Kingdom
Contacts
Public ContactBeth Bateson
Outcome results
None listed